Brigitte Schiller - Jul 15, 2022 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role: Director
Signature: /s/ Brigitte Schiller
Stock symbol: UNCY
Transactions as of: Jul 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/30/2022, 05:01 PM
Previous filing: May 17, 2022
SEC: View on sec.gov

This filing has been restated, see here for the amended filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UNCY	Common Stock	Options Exercise	$0	+26.7K		$0.00	26.7K	Jul 15, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UNCY	Restricted Stock Units	Options Exercise	$0	-26.7K	-100%	$0.00^*	0	Jul 15, 2022	Common Stock	26.7K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022.
F2	Each restricted stock unit is the economic equivalent of one share of Unicycive Therapeutics common stock.
F3	On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022. The common stock into which such vested restricted stock units converted on July 15, 2022 is reported in Table I on this Form 4.